Invention Grant
- Patent Title: Imidazoquinoline compounds and prodrugs thereof
-
Application No.: US17598160Application Date: 2020-04-16
-
Publication No.: US12295970B2Publication Date: 2025-05-13
- Inventor: Laird Forrest , Daniel Aires , Ryan Moulder , Ruolin Lu , Jordan Hunt , Peter Kleindl , Ti Zhang , Chad Groer , Shuang Cai
- Applicant: UNIVERSITY OF KANSAS , HYLAPHARM, LLC
- Applicant Address: US KS Lawrence; US KS Lawrence
- Assignee: UNIVERSITY OF KANSAS,HYLAPHARM, LLC
- Current Assignee: UNIVERSITY OF KANSAS,HYLAPHARM, LLC
- Current Assignee Address: US KS Lawrence; US KS Lawrence
- Agency: Foley & Lardner LLP
- International Application: PCT/US2020/028468 WO 20200416
- International Announcement: WO2020/214783 WO 20201022
- Main IPC: A61K33/243
- IPC: A61K33/243 ; A61K45/06 ; A61K47/36 ; A61K47/61 ; A61P29/00 ; A61P35/00 ; C07D471/04 ; C07F15/00
Abstract:
The present technology is directed to TLR7 and TLR8 agonist compounds, compositions, and methods of using the same for the treatment of cancers and as vaccine adjuvants.
Public/Granted literature
- US20220177472A1 IMIDAZOQUINOLINE COMPOUNDS AND PRODRUGS THEREOF Public/Granted day:2022-06-09
Information query
